Market growth is largely driven by factors such as the growing global prevalence of kidney diseases and urinary tract infections, the shift towards automation in sediment analysis, and the increasing adoption of point-of-care urinalysis. Integrated systems for urinalysis and the emerging economies are expected to provide a wide range of growth opportunities for players in the market.

Market Size

The global Urinalysis Market is projected to reach USD 4.6 billion by 2024 from USD 3.2 billion in 2019, at a CAGR of 7.6% from 2019 to 2024

To know about the assumptions considered for the study download the pdf brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153479294

“Pregnancy and fertility tests to dominate the urinalysis market in 2019.”

On the basis of test type, the urinalysis market is segmented into biochemical urinalysis, sediment urinalysis, and pregnancy & fertility tests. In 2019, pregnancy & fertility tests are expected to account for the largest market share. Growing use of these kits in home care settings is driving the growth of this segment.

“Hospitals & clinics expected to dominate the urinalysis market in 2019.”

By end user, the urinalysis market is segmented into hospitals & clinics, diagnostic laboratories, home care settings, and research laboratories & institutes. In 2019, hospitals & clinics are expected to account for the largest share of 40% of the market. The large share of this segment can be attributed to factors such as the rapidly growing aging population, the increase in reimbursements for clinical tests performed in hospitals, and the launch of automated urinalysis devices.

 Recent Developments

• In 2018, Beckman Coulter launched IQ Workcell 3000 and 2000.
• In 2018, DIRUI Industrial Co. Ltd. Launched the FUS 1000 Automated Urine Analyzer.
• In 2018, Beckman Coulter and Arkray formed a partnership to deliver integrated urine analyzers.

For More Details, Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=153479294

The global urinalysis market is projected to reach USD 4.6 billion by 2024 from USD 3.2 billion in 2019, at a CAGR of 7.6% from 2019 to 2024.

Market growth is largely driven by factors such as the growing global prevalence of kidney diseases and urinary tract infections, the shift towards automation in sediment analysis, and the increasing adoption of point-of-care urinalysis.

The urinalysis market is segmented into biochemical urinalysis, sediment urinalysis, and pregnancy & fertility tests. In 2019, pregnancy & fertility tests are expected to account for the largest market share. Growing use of these kits in home care settings is driving the growth of this segment.

Download PDF Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153479294

The urinalysis market is segmented into hospitals & clinics, diagnostic laboratories, home care settings, and research laboratories & institutes. In 2019, hospitals & clinics are expected to account for the largest share of 40% of the market. The large share of this segment can be attributed to factors such as the rapidly growing aging population, the increase in reimbursements for clinical tests performed in hospitals, and the launch of automated urinalysis devices.

The urinalysis market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2019, North America commanded the largest share of the urinalysis market. The large share of this market segment can be attributed to the increasing incidence of chronic kidney diseases and UTIs as well as the increasing adoption of technologically advanced automated devices in the region.

Request Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=153479294

The major players operating in this market are Siemens Healthineers (Germany), Roche Diagnostics (Switzerland), Cardinal Health (US), Arkray Inc. (Japan), Sysmex Corporation (Japan), Alere Inc. (US), Beckman Coulter (US), Biorad Laboratories (US), 77 Elektronika Kft (Hungary), and DIRUI (China).

The global Urinalysis market is segmented on the basis of product, application, end user, and region. Market growth is largely driven by factors such as the growing global prevalence of kidney diseases and urinary tract infections, the shift towards automation in sediment analysis, and the increasing adoption of point-of-care urinalysis.

On the basis of test type, the urinalysis market is segmented into biochemical urinalysis, sediment urinalysis, and pregnancy & fertility tests. In 2019, pregnancy & fertility tests are expected to account for the largest market share. Growing use of these kits in home care settings is driving the growth of this segment.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153479294

Based on application, the urinalysis market is segmented into disease screening and pregnancy and fertility. In 2019, the disease screening segment accounted for the largest market share owing to the fact that urine analysis has become a part of the general check-up in hospitals and clinics. Pregnancy and fertility testing is carried out using the kits available in the market either in home care settings or in clinics.

By end user, the urinalysis market is segmented into hospitals & clinics, diagnostic laboratories, home care settings, and research laboratories & institutes. In 2019, hospitals & clinics are expected to account for the largest share of 40% of the market. The large share of this segment can be attributed to factors such as the rapidly growing aging population, the increase in reimbursements for clinical tests performed in hospitals, and the launch of automated urinalysis devices.

Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=153479294

On the basis of region, the urinalysis market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2019, North America commanded the largest share of the urinalysis market. The large share of this market segment can be attributed to the increasing incidence of chronic kidney diseases and UTIs as well as the increasing adoption of technologically advanced automated devices in the region.

The major players operating in this market are Siemens Healthineers (Germany), Roche Diagnostics (Switzerland), Cardinal Health (US), Arkray Inc. (Japan), Sysmex Corporation (Japan), Alere Inc. (US), Beckman Coulter (US), Biorad Laboratories (US), 77 Elektronika Kft (Hungary), and DIRUI (China).

Read More@
https://www.marketsandmarkets.com/PressReleases/urinalysis-systems.asp

According to the new market research “Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, PoC Analyzers), Application (UTI, Diabetes, Pregnancy), End User (Hospital, Labs, Homecare) & Test Type - Global Forecast to 2024", analyzes and studies the major market drivers, restraints/challenges, and opportunities. The global urinalysis market is projected to reach USD 4.6 billion by 2024 from USD 3.2 billion in 2019, at a CAGR of 7.6% from 2019 to 2024.

The global Urinalysis market is segmented based on product, application, end user, test type and regions

The urinalysis market, based on product type, is segmented into consumables and instruments. The consumables segment dominated this market in 2019. The urinalysis consumables market is segmented into pregnancy & fertility kits, dipsticks, reagents, and disposables. Pregnancy and fertility kits accounted for the largest share of this market in 2019. These kits have witnessed wide adoption amongst end users across the globe owing to their cost-effectiveness and ease of use.

Download a PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153479294

Browse and in-depth TOC on in “Urinalysis Market " 
119 - Tables
37 - Figures 
146 - Pages 

Based on application, the urinalysis market is segmented into disease screening and pregnancy and fertility. In 2019, the disease screening segment accounted for the largest market share owing to the fact that urine analysis has become a part of the general check-up in hospitals and clinics. Pregnancy and fertility testing is carried out using the kits available in the market either in home care settings or in clinics.

Request Free Sample Report @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=153479294

On the basis of region, the urinalysis market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2019, North America commanded the largest share of the urinalysis market. The large share of this market segment can be attributed to the increasing incidence of chronic kidney diseases and UTIs as well as the increasing adoption of technologically advanced automated devices in the region.

Market Players

The key players in the Urinalysis market are Siemens Healthineers (Germany), Roche Diagnostics (Switzerland), Cardinal Health (US), Arkray Inc. (Japan), Sysmex Corporation (Japan), Alere Inc. (US), Beckman Coulter (US), Biorad Laboratories (US), 77 Elektronika Kft (Hungary), and DIRUI (China).

View Complete Press Release @ 
https://www.marketsandmarkets.com/PressReleases/urinalysis-systems.asp

According to the latest research report "Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, PoC Analyzers), Application (UTI, Diabetes, Pregnancy), End User (Hospital, Labs, Homecare) & Test Type - Global Forecast to 2024"

The global urinalysis market is projected to reach USD 4.6 billion by 2024 from USD 3.2 billion in 2019, at a CAGR of 7.6% from 2019 to 2024. 

Integrated systems for urinalysis and the emerging economies are expected to provide a wide range of growth opportunities for players in the market which is driven by growing incidences of UTI and other kidney diseases.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153479294

 

 

The study involved four major activities to estimate the current size of the urinalysis market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. 

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for this study.

Primary Research

Several stakeholders such as urinalysis manufacturers, vendors, distributors and scientists, researchers, laboratory technicians, and doctors from hospitals and clinics were consulted for this report. The demand side of this market is characterized by significant use of urinalysis due to increasing cancer, diabetes, chronic wounds, musculoskeletal disorders and the growing aging population across the globe. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.

Get Sample Report with all Graphs & Charts related to it @: https://www.marketsandmarkets.com/requestsampleNew.asp?id=153479294

Urinalysis Market segmentation: 

• Based on Product
• Based on Test Type
• Based on Application
• Based on End Users
• Based on Regions

The Major Players Opearting in the Urinalysis Market : 

Key players in the Seimens Healthineers (Germany), Roche Diagnostics (Switzerland), Cardinal Health (US), Arkray Inc (Japan), Sysmex Corporation (Japan), Alere Inc. (US), Beckman Coulter (US), Bio-Rad Laboratories (US), 77 Elektronika Kft (Hungary), and DIRUI (China), ACON Laboratories (US), Quidel Corporation (US) and URIT Medical Electronic Ltd. (China).